Applications of Diisopropyl D-Tartrate in Industrial Manufacturing

Diisopropyl D-Tartrate serves as a chiral additive and intermediate in fine chemical manufacturing. Its optical purity and functional groups support enantioselective processes across specialized production environments. We manufacture this product to serve applications that depend on stringent purity, traceability, and process repeatability.

1. Chiral Catalyst Preparation for Asymmetric Hydrogenation

Pharmaceutical manufacturers use diisopropyl D-tartrate as a key chiral ligand in the Sharpless asymmetric dihydroxylation and related hydrogenation systems. Its stereochemical integrity enables enantiomeric enrichment during metal-catalyzed transformations. This material enters catalyst preparation steps under controlled conditions, allowing precise adjustment of ligand-to-metal ratios for optimal turnover and selectivity specific to the target API. Each production campaign demands traceable batch records conforming to regulated protocols.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP General Chapter <823> Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging
• EMA Guidelines on the Requirements for Quality Documentation Concerning Biological Investigational Medicinal Products

Typical usage ratio

• Ranges from 0.1 to 1.5 molar equivalents relative to metal center, adjusted based on substrate structure and enantioselectivity targets.

Downstream process integration

• Introduced during in situ complexation with transition metals (e.g., Ru, Rh, Os) within catalyst synthesis reactors. Used as preformed ligand solutions or added directly under inert atmosphere before set-up of hydrogenation.

Final product types

• Chiral pharmaceutical intermediates
• Enantiomerically pure active pharmaceutical ingredients (APIs)
• Asymmetric hydrogenation catalyst complexes
• Chemical building blocks for contract development and manufacturing (CDMO) partners

2. Intermediate for Stereoselective Synthesis of Agrochemical Actives

Agrochemical producers integrate diisopropyl D-tartrate into stereoselective syntheses of crop protection active ingredients, particularly where enantiopure intermediates dictate biological activity. Its stereochemistry supports epoxidation and dihydroxylation processes in pilot and industrial plants synthesizing fungicides, herbicides, and insecticide actives. Strict segregation and documentation systems apply during campaigning of chiral synthesis routes, tracked from raw material release through to the isolated active.

Industry compliance standards

• FAO/WHO Specifications for Chemical Pesticides
• ISO 9001:2015 Quality Management Systems for Crop Protection Manufacturing
• REACH (EC) No 1907/2006 Registration for agrochemical intermediates
• National compliance with China Pesticide Management Regulations (农药管理条例, PRC)

Typical usage ratio

• Typically 0.2-1.2 molar equivalents in ligand- or template-guided chiral synthesis, with precise dosing set by target compound and batch scale.

Downstream process integration

• Dosed as a chiral auxiliary or ligand in early- to mid-stage synthesis vessels, usually followed by work-up and purification of chiral intermediates under closed-system protocols.

Final product types

• Enantiopure agrochemical active ingredients
• Chiral intermediates for bulk pesticide synthesis
• Template-based herbicide building blocks
• Stereochemically defined fungicides

3. Fine Chemical Manufacturing for Flavors and Fragrances

Producers of aroma chemicals leverage the chiral properties of diisopropyl D-tartrate to synthesize enantiopure molecules used in high-end flavors and fragrances. The compound enables the formation of optically active alcohols and acids through non-racemic oxidation and reduction protocols. Batch records and cleaning validations must fully comply with food safety and quality management systems, supporting both food-grade and specialty perfumery production.

Industry compliance standards

• FSSC 22000 Food Safety Management System
• IFRA Standards (International Fragrance Association)
• FDA 21 CFR Part 172—Food Additives Permitted for Direct Addition to Food for Human Consumption
• ISO 9001:2015 for Fragrance Ingredient Manufacturing

Typical usage ratio

• Employs levels of 0.5-2.0 molar equivalents, modulated for selectivity and product profile; adjusted per batch based on GC/MS analysis of chiral purity.

Downstream process integration

• Added at the enantioselective oxidation, reduction, or esterification step in batch or semi-batch reactors; included during work-up before distillation or isolation of target aroma compounds.

Final product types

• Natural and synthetic linalool
• (R)-α-ionone and related optically pure terpenes
• Chiral alcohols for luxury fragrance houses
• Food-grade esters and acids for beverage and candy applications

4. Laboratory Scale Synthesis for Research and Development

Research chemistry laboratories engage diisopropyl D-tartrate in small-scale asymmetric reactions, screening studies, and development of novel chiral catalysts. Academic and contract research groups set rigorous documentation on incoming material origin, purity, and batch homogeneity. Correct handling protocols and chain-of-custody records support compliance for discovery projects and technology transfer to pilot scale. Traceability and experiment reproducibility drive batch selection and usage monitoring in R&D environments.

Industry compliance standards

• ISO/IEC 17025:2017—General requirements for the competence of testing and calibration laboratories
• GLP (Good Laboratory Practice) Guidelines OECD 1–13
• Institutional chemical safety and documentation protocols

Typical usage ratio

• Commonly 0.05-1.0 molar equivalents in reaction screens or catalyst development; researchers adjust ratios based on substrate and method optimization.

Downstream process integration

• Added to bench-scale reactors or automated screening systems at chiral catalyst or ligand preparation stages, and tracked in batch records for each experiment set.

Final product types

• Characterized chiral catalysts for asymmetric synthesis
• Method development samples for publication or patent
• Screening intermediates for process transfer
• Reference materials distributed for QC method validation